Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,865,158
+$1,399,226 QoQ
Shares Held
19,853
+20.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2026CallValue
$44,654
CallShares
100
PutValue
$9,600,610
PutShares
21,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LMR Partners LLP holds $133,764,593 across 60 Biotechnology names. VRTX ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
74,661 | $24,703,084 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
324,939 | $18,355,804 | |
| 3 | ARGX |
Argenx SE
|
23,488 | $17,152,112 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
130,000 | $12,642,500 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
116,444 | $9,771,980 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
19,853 | $8,865,158 | |
| 7 | ABVX |
Abivax S.A.
|
76,552 | $8,524,065 | |
| 8 | NKTR |
Nektar Therapeutics
|
48,294 | $3,474,753 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,600,610 | 21,500 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $8,865,158 | 19,853 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $44,654 | 100 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $7,465,932 | 16,468 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $2,266,800 | 5,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $1,958,200 | 5,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $6,305,795 | 16,101 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $2,855,104 | 5,889 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $58,472,040 | 145,200 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $40,270 | 100 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $37,773,662 | 93,801 | Shares | Other | 2025-02-14 | |
| 2024-03-31 | $3,138,837 | 7,509 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,596,093 | 8,838 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $23,518,242 | 57,800 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $4,190,967 | 10,300 | Call | Sole | 2024-02-14 | |
| 2022-12-31 | $4,220,230 | 14,614 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,495,469 | 18,980 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,959,713 | 14,052 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $696,789 | 2,670 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $595,994 | 2,714 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,485,073 | 68,830 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $25,096,886 | 124,470 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $915,861 | 4,262 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,778,840 | 15,989 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $691,729 | 2,542 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $12,795,122 | 44,074 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||